US Group Raises Pricing Recommendation For Gilead's Remdesivir In COVID

Gilead Sciences Inc's antiviral remdesivir could be priced up to $5,080 per course based on benefits shown in COVID-19 patients, a U.S. drug pricing research group suggested on Wednesday, above its...

from NDTV News - Latest https://ift.tt/3hX2lsF

Comments

Popular posts from this blog

"Modi Does What He Promises": PM On Why People Trust His 'Guarantees'

'800-Strong Mob Intended To Cause Death': Probe Agency On Bengal Attack